Department of Medical Genetics, University of Alberta, Edmonton, Alberta, Canada.
National Center for Biotechnology Information, National Institutes of Health, Bethesda, Maryland, USA.
Am J Med Genet C Semin Med Genet. 2020 Sep;184(3):860-868. doi: 10.1002/ajmg.c.31844. Epub 2020 Sep 8.
Current genetic screening methods for inherited eye diseases are concentrated on the coding exons of known disease genes (gene panels, clinical exome). These tests have a variable and often limited diagnostic rate depending on the clinical presentation, size of the gene panel and our understanding of the inheritance of the disorder (with examples described in this issue). There are numerous possible explanations for the missing heritability of these cases including undetected variants within the relevant gene (intronic, up/down-stream and structural variants), variants harbored in genes outside the targeted panel, intergenic variants, variants undetectable by the applied technology, complex/non-Mendelian inheritance, and nongenetic phenocopies. In this article we further explore and review methods to investigate these sources of missing heritability.
目前遗传性眼病的基因筛查方法主要集中在已知疾病基因的编码外显子上(基因组合、临床外显子组)。这些检测的诊断率各不相同,且往往有限,这取决于临床表现、基因组合的大小以及我们对疾病遗传方式的理解(本期刊登了一些例子)。对于这些病例的遗传缺失有很多可能的解释,包括相关基因内未检测到的变异(内含子、上下游和结构变异)、靶向组合外的基因中的变异、基因间变异、应用技术无法检测到的变异、复杂/非孟德尔遗传以及非遗传表型模拟。在本文中,我们进一步探讨和回顾了调查这些遗传缺失来源的方法。